1
|
6576872293
|
DO BAQI21-2532, , DECLARACION 4 DE 5 NUMERO DE CATALOGO/REF: 1043728. PRODUCTO: ASPARTAME COMPUESTO RELACIONADO A CATAL
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
ESPAÑA
|
0.01 Kgs
|
0.01 KG
|
2
|
6576872293
|
DO BAQI21-2532, , DECLARACION 1 DE 5 NUMERO DE CATALOGO REF: 1463701. PRODUCTO: NIFEDIPINO NITROSOFENILPIRIDINA ANALOGO
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
INDIA
|
0.01 Kgs
|
0.01 KG
|
3
|
6576872293
|
DO BAQI21-2532, , DECLARACION 4 DE 5 NUMERO DE CATALOGO/REF: 1043728. PRODUCTO: ASPARTAME COMPUESTO RELACIONADO A CATAL
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
ESPAÑA
|
0.01 Kgs
|
0.01 KG
|
4
|
6576872293
|
DO BAQI21-2532, , DECLARACION 1 DE 5 NUMERO DE CATALOGO REF: 1463701. PRODUCTO: NIFEDIPINO NITROSOFENILPIRIDINA ANALOGO
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
INDIA
|
0.01 Kgs
|
0.01 KG
|
5
|
6576872293
|
DO BAQI21-2532, , DECLARACION 4 DE 5 NUMERO DE CATALOGO/REF: 1043728. PRODUCTO: ASPARTAME COMPUESTO RELACIONADO A CATAL
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
ESPAÑA
|
0.01 Kgs
|
0.01 KG
|
6
|
6576872293
|
DO BAQI21-2532, , DECLARACION 1 DE 5 NUMERO DE CATALOGO REF: 1463701. PRODUCTO: NIFEDIPINO NITROSOFENILPIRIDINA ANALOGO
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
INDIA
|
0.01 Kgs
|
0.01 KG
|
7
|
6576872293
|
DO BAQI21-2532, , DECLARACION 4 DE 5 NUMERO DE CATALOGO/REF: 1043728. PRODUCTO: ASPARTAME COMPUESTO RELACIONADO A CATAL
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
ESPAÑA
|
0.01 Kgs
|
0.01 KG
|
8
|
6576872293
|
DO BAQI21-2532, , DECLARACION 1 DE 5 NUMERO DE CATALOGO REF: 1463701. PRODUCTO: NIFEDIPINO NITROSOFENILPIRIDINA ANALOGO
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
INDIA
|
0.01 Kgs
|
0.01 KG
|
9
|
6576872293
|
DO BAQI21-2532, , DECLARACION 4 DE 5 NUMERO DE CATALOGO/REF: 1043728. PRODUCTO: ASPARTAME COMPUESTO RELACIONADO A CATAL
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
ESPAÑA
|
0.01 Kgs
|
0.01 KG
|
10
|
6576872293
|
DO BAQI21-2532, , DECLARACION 1 DE 5 NUMERO DE CATALOGO REF: 1463701. PRODUCTO: NIFEDIPINO NITROSOFENILPIRIDINA ANALOGO
|
C.I FARMACAPSULAS S.A.
|
USP U.S PHARMACOPEIAL CONVENTION
|
2021-12-30
|
INDIA
|
0.01 Kgs
|
0.01 KG
|